PAN DRUG RECALL TRIGGERS 320,000 HOT LINE CALLS

admin's picture

MELBOURNE, Australia (Radio Australia, May 2) - Australian
authorities have published what they believe is the final list of products to be
withdrawn from sale as part of the nation's biggest medical product recall.

The recall was ordered following the suspension of the
manufacturing license of complementary medicine maker, Pan Pharmaceuticals.

The suspension came after an audit of Pan by Australia's
pharmaceutical industry watchdog, the Theraputic Goods Administration - TGA.

The audit alleged serious problems with the company's practices.

From Sydney Trevor Thompson reports another 701 products have
been added to the TGA's Pan-related recall list, bringing the total to 1,369.

A hotline set up for public enquiries has received 320,000 calls
in its first two days of operation.

Pan Pharmaceuticals founder Jim Selim has resigned as chief
executive of the company.

However, he remains a non-executive director and is still the
controlling shareholder.

That is a situation the Parliamentary Secretary for Health,
Trish Worth says will be a factor as the TGA determines when to lift the
suspension of Pan's manufacturing license.

May 2, 2003

Radio Australia: www.abc.net.au/ra

Rate this article: 
No votes yet

Add new comment